Cascade Technologies Corp  

(Public, OTCMKTS:CSDT)   Watch this stock  
Find more results for EUGENE FARKAS
0.0087
+0.0003 (3.57%)
Delayed:   9:46AM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.01 - 0.01
52 week 0.00 - 0.03
Open 0.01
Vol / Avg. 2,000.00/43,332.00
Mkt cap 1.87M
P/E     -
Div/yield     -
EPS -0.01
Shares 214.79M
Beta -47.72
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -292.24% -585.24%
Return on average equity - -
Employees 3 -
CDP Score - -

Address

Suite 427, 250 N. Robertson Blvd.
BEVERLY HILLS, CA 90211
United States - Map
+1-310-8581670 (Phone)

Website links

Description

Cascade Technologies Corp. (Cascade) is a development-stage, medical imaging device company. All medical device operations are being conducted by Cascade�s wholly owned subsidiary, Spectral Molecular Imaging, Inc. (SMI). Cascade focuses to develop three products, which include the SkinSpect device, the EndoSpect device, and the OxySpect device. During the year ended December 31, 2010, the Company had not generated any revenues. In March 2010, the Company acquired Spectral Molecular Imaging, Inc.

Officers and directors

Daniel L. Farkas Ph.D. Chairman of the Board, Acting Chief Executive Officer
Age: 60
Eugene Scher Chief Financial Officer, Chief Operating Officer, Director
Age: 63